Esperion Therapeutics Q1 EPS $0.34 Beats $0.05 Estimate, Sales $137.74M Beat $84.51M Estimate
Esperion Therapeutics Q1 EPS $0.34 Beats $0.05 Estimate, Sales $137.74M Beat $84.51M Estimate
Esperion Therapeutics第一季度每股收益0.34美元超过预期的0.05美元，销售额1.3774亿美元超过8451万美元的预期
Esperion Therapeutics (NASDAQ:ESPR) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.05 by 580 percent. This is a 143.04 percent increase over losses of $(0.79) per share from the same period last year. The company reported quarterly sales of $137.74 million which beat the analyst consensus estimate of $84.51 million by 62.98 percent. This is a 466.14 percent increase over sales of $24.33 million the same period last year.
Esperion Therapeutics（纳斯达克股票代码：ESPR）公布的季度收益为每股0.34美元，比分析师普遍预期的0.05美元高出580％。这比去年同期每股亏损0.79美元（0.79美元）增长了143.04％。该公司公布的季度销售额为1.374亿美元，比分析师普遍预期的8,451万美元高出62.98％。这比去年同期的2433万美元的销售额增长了466.14％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。